In fact, IL2RA+CD4+ T-cells from severe COVID-19 patients expressed Th1, Th2, and IL-10 signature genes more frequently (Figure 3F) whereas Th17 differentiation was suppressed in IL2RA+ T-cells from both groups. The gene discussed is IL2RA; the disease is COVID-19.